Congress will not pass standalone federal psychedelic rescheduling legislation before FDA approval; any advancing measure will be veteran-focused pilot programs.

Rather than passing a broad law to change how psychedelics are classified, Congress will focus any psychedelic action narrowly on military veterans — a group with strong political sympathy on both sides of the aisle. Full rescheduling legislation has almost no political momentum, but small pilot programs for veterans with PTSD (post-traumatic stress disorder) give politicians a safe, popular thing to support. This shapes who gets early access — mostly veterans, not the general public.

Veteran framing provides bipartisan cover; standalone rescheduling lacks constituent support. Falsifiable: passage of a non-veteran-framed standalone rescheduling bill before FDA approval would break this prediction.